ConductScience.org, home

Paper1069608

Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.

Wiernik PH and 6 others. Cancer Treat Rep, 1976. Cited by 89 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia. Papers, record 1069608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1069608

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
4.17
iCite
Revised in PubMed
2013-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wiernik PHP H
2Schimpff SCS C
3Schiffer CAC A
4Lichtenfeld JLJ L
5Aisner JJ
6O'Connell MJM J
7Fortner CC

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
LeukemiaMajor topic
Acute Disease
Aged
Bone Marrow
Central Nervous System Diseases
Cyclophosphamide
Cytarabine
Daunorubicin
Drug Therapy, Combination
Female
Guanazole
Humans
Leukemia, Myeloid, Acute
Male
Meninges
Middle Aged
Pyrimethamine
Remission, Spontaneous
Skin Tests
Thioguanine

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
34,068,720OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.Cells2021https://conductscience.org/library/papers/34068720PubMed
27,517,413Acute myeloid leukaemia-A review of sixty-seven cases.Ir J Med Sci1979https://conductscience.org/library/papers/27517413PubMed
8,968,695A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.Drug Saf1996https://conductscience.org/library/papers/8968695PubMed
7,347,042Remission-induction regimens in acute nonlymphocytic leukemia.West J Med1980https://conductscience.org/library/papers/7347042PubMed
6,961,971Uptake and metabolism of daunorubicin by human leukemia cells.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961971PubMed
3,207,892Experiences with the Ommaya reservoir for prophylaxis and treatment of the central nervous system in adult acute myelocytic leukemia.Blut1988https://conductscience.org/library/papers/3207892PubMed
98,107Infection in acute leukemia patients receiving oral nonabsorable antibiotics.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/98107PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1069608

GET https://conductscience.org/api/papers/v1/1069608/authors